Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for ...
Scientists have developed a new iron-based catalyst that improves the typically low hydrogen atom economy (HAE) in the direct ...
Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...
Tirzepatide's dual mechanism targets GIP and GLP-1, so it provides strong cardiovascular benefits, said Stephen Nicholls, ...
Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, ...